325 related articles for article (PubMed ID: 30303110)
21. Chimeric antigen receptor T-cell therapy beyond cancer: current practice and future prospects.
Zhang PF; Xie D; Li Q
Immunotherapy; 2020 Sep; 12(13):1021-1034. PubMed ID: 32727249
[TBL] [Abstract][Full Text] [Related]
22. CAR-T cell therapy and infection: a review.
Bupha-Intr O; Haeusler G; Chee L; Thursky K; Slavin M; Teh B
Expert Rev Anti Infect Ther; 2021 Jun; 19(6):749-758. PubMed ID: 33249873
[No Abstract] [Full Text] [Related]
23. [CAR-T cells and bispecific antibodies: An update on these major therapeutic advances].
Bay JO; Caux C
Bull Cancer; 2021 Oct; 108(10S):S1-S3. PubMed ID: 34920792
[No Abstract] [Full Text] [Related]
24. CAR-T cells beyond CD19, UnCAR-Ted territory.
Leick MB; Maus MV
Am J Hematol; 2019 May; 94(S1):S34-S41. PubMed ID: 30632631
[TBL] [Abstract][Full Text] [Related]
25. Off the shelf T cell therapies for hematologic malignancies.
McCreedy BJ; Senyukov VV; Nguyen KT
Best Pract Res Clin Haematol; 2018 Jun; 31(2):166-175. PubMed ID: 29909917
[TBL] [Abstract][Full Text] [Related]
26. Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells.
Friedman KM; Garrett TE; Evans JW; Horton HM; Latimer HJ; Seidel SL; Horvath CJ; Morgan RA
Hum Gene Ther; 2018 May; 29(5):585-601. PubMed ID: 29641319
[TBL] [Abstract][Full Text] [Related]
27. CAR T cells - what have we learnt?
Nat Rev Clin Oncol; 2017 Dec; 15(1):1. PubMed ID: 29242589
[No Abstract] [Full Text] [Related]
28. Chimeric Antigen Receptor (CAR) T-Cell Therapy.
Pagel JM; West HJ
JAMA Oncol; 2017 Nov; 3(11):1595. PubMed ID: 28880983
[No Abstract] [Full Text] [Related]
29. [Not Available].
Caux C; Bay JO
Bull Cancer; 2018 Dec; 105 Suppl 2():S133-S134. PubMed ID: 30686351
[No Abstract] [Full Text] [Related]
30. The market for chimeric antigen receptor T cell therapies.
Yip A; Webster RM
Nat Rev Drug Discov; 2018 Mar; 17(3):161-162. PubMed ID: 29375140
[No Abstract] [Full Text] [Related]
31. Improving CAR T cell therapy by optimizing critical quality attributes.
Reddy OL; Stroncek DF; Panch SR
Semin Hematol; 2020 Apr; 57(2):33-38. PubMed ID: 32892841
[TBL] [Abstract][Full Text] [Related]
32. Next Steps in the CAR Journey of a Thousand Miles.
Brenner MK
Mol Ther; 2017 Oct; 25(10):2226-2227. PubMed ID: 28939089
[No Abstract] [Full Text] [Related]
33. What's in Your CART? Clinical insights on challenges in mononuclear cell collection for CAR-T therapy.
Annen K; Zubair A; Schwartz E; Schwartz J; Szczepiorkowski ZM
J Clin Apher; 2020 Jun; 35(3):234-235. PubMed ID: 32186782
[No Abstract] [Full Text] [Related]
34. [Not Available].
Gauthier J
Bull Cancer; 2018 Dec; 105 Suppl 2():S214-S217. PubMed ID: 30686360
[TBL] [Abstract][Full Text] [Related]
35. Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safety.
Halim L; Ajina A; Maher J
Best Pract Res Clin Haematol; 2018 Jun; 31(2):117-125. PubMed ID: 29909912
[TBL] [Abstract][Full Text] [Related]
36. [CAR-T cells in acute lymphoblastic leukemias: What's new?].
Grain A; Dourthe ME; Baruchel A
Bull Cancer; 2020 Feb; 107(2):234-243. PubMed ID: 32035651
[TBL] [Abstract][Full Text] [Related]
37. CAR T-Cells and Safety Signals: ITT Episode 29.
N Engl J Med; 2024 Apr; 390(16):e39. PubMed ID: 38657243
[No Abstract] [Full Text] [Related]
38. CAR-T in the clinic: drive with care.
Yáñez-Muñoz RJ; Grupp SA
Gene Ther; 2018 Jun; 25(3):157-161. PubMed ID: 29961080
[No Abstract] [Full Text] [Related]
39. Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia.
Prommersberger S; Jetani H; Danhof S; Monjezi R; Nerreter T; Beckmann J; Einsele H; Hudecek M
Curr Res Transl Med; 2018 May; 66(2):37-38. PubMed ID: 29655962
[No Abstract] [Full Text] [Related]
40. T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies.
Tang L; Zhang Y; Hu Y; Mei H
Biomed Res Int; 2021; 2021():6616391. PubMed ID: 33728333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
